Nucleic-Acid Delivery Using Lipid Nanocapsules.
In conclusion, LNCs are very good candidates to deliver nucleic acids to cells in the course of anti-cancer therapies.
PMID: 27033510 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Lagarce F, Passirani C Tags: Curr Pharm Biotechnol Source Type: research
More News: Biotechnology | Brain Tumor | Cancer | Cancer & Oncology | Cancer Therapy | Glioma | Melanoma | Nanotechnology | Skin Cancer | Toxicology